|
Index of reports
> Life Threatening Events (67)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Kaletra (Lopinavir / Ritonavir) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 67 Next >>
Possible Kaletra side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-24
Patient: male
Reactions: Renal Failure, Coma, Convulsion
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Acetaminophen
Indication: Pain
Start date: 2012-07-11
Acupan
Indication: Pain
Start date: 2012-07-16
End date: 2012-07-27
Amikacin
Indication: Atypical Mycobacterium Pericarditis
Start date: 2012-07-11
Bactrim
Administration route: Oral
Indication: Atypical Mycobacterium Pericarditis
Start date: 2012-07-13
Cernevit-12
Indication: Vitamin Supplementation
Start date: 2012-07-10
End date: 2012-08-02
Clarithromycin
Administration route: Oral
Indication: Atypical Mycobacterium Pericarditis
Start date: 2012-07-11
Isentress
Administration route: Oral
Indication: HIV Infection
Start date: 2012-05-01
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Leucovorin Calcium
Administration route: Oral
Start date: 2012-07-10
Myambutol
Dosage: 2 units
Administration route: Oral
Start date: 2012-07-11
Olanzapine
Dosage: 1 unit
Administration route: Oral
Start date: 2012-01-01
Perikabiven
Indication: Parenteral Nutrition
Start date: 2012-07-10
Potassium Chloride
Administration route: Oral
Start date: 2012-07-10
Prazepam
Dosage: 1 unit
Administration route: Oral
Start date: 2012-07-10
Rifabutin
Administration route: Oral
Indication: Atypical Mycobacterium Pericarditis
Start date: 2012-07-11
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Possible Kaletra side effects in male
Reported by a physician from Chile on 2012-08-24
Patient: male, weighing 87.0 kg (191.4 pounds)
Reactions: Asthmatic Crisis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Lamivudine (Epivir Hbv); Escitalopram; Valproic Acid; Flemar; Clotiazepam; Acyclovir
Possible Kaletra side effects in male
Reported by a physician from Japan on 2012-08-24
Patient: male, weighing 59.5 kg (130.9 pounds)
Reactions: Pulmonary Hypertension, Hepatic Function Abnormal, Fibrin Degradation Products Increased, Nausea, Tremor, Palpitations, Visual Impairment, Dizziness, Nervous System Disorder, Influenza Like Illness
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Abacavir Sulfate
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-07-25
Abacavir Sulfate
Administration route: Oral
Start date: 2001-10-20
End date: 2001-10-27
Didanosine
Administration route: Oral
Start date: 2001-07-21
End date: 2004-05-14
Didanosine
Administration route: Oral
Indication: HIV Infection
Start date: 1994-11-19
End date: 2001-07-21
Efavirenz
Administration route: Oral
Start date: 2000-09-25
End date: 2000-10-02
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-07-25
Indinavir
Administration route: Oral
Indication: HIV Infection
Start date: 2000-03-08
End date: 2000-05-24
Kaletra
Administration route: Oral
Indication: HIV Infection
End date: 2004-04-24
Lamivudine
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-15
End date: 2008-09-19
Norvir
Administration route: Oral
Start date: 2008-09-20
Norvir
Administration route: Oral
Start date: 2004-04-25
End date: 2008-09-19
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2000-12-24
Peginterferon Alfa-2B
Indication: Hepatitis C
Start date: 2002-08-17
End date: 2003-07-12
Saquinavir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2000-03-18
Saquinavir
End date: 2001-03-31
Saquinavir
Administration route: Oral
Start date: 2000-05-24
End date: 2000-12-24
Stavudine
Dosage: daily
Administration route: Oral
Indication: HIV Infection
Start date: 1997-08-25
End date: 2001-10-20
Other drugs received by patient: Truvada; Amlodipine Besylate; Lexiva; Coagulation Factor Viii; Olmesartan Medoxomil; Tenofovir Disoproxil Fumarate; Isentress; Cross Eight M; Ribavirin; Coagulation Factor Viii; Ribavirin; Atazanavir
Possible Kaletra side effects in male
Reported by a physician from Japan on 2012-08-22
Patient: male
Reactions: Hypophosphataemia, Diarrhoea, Cardiac Failure, Lactic Acidosis, Liver Disorder
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Abacavir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-08-31
End date: 2006-09-21
Didanosine
Administration route: Oral
Indication: HIV Infection
Start date: 2002-09-03
End date: 2004-08-04
Didanosine
Administration route: Oral
Start date: 2004-08-31
End date: 2006-09-21
Didanosine
Administration route: Oral
Start date: 2006-10-26
Isentress
Dosage: 800mg daily
Administration route: Oral
Indication: HIV Infection
Start date: 2011-08-07
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2002-09-03
End date: 2004-08-04
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2006-10-26
End date: 2011-08-07
Kaletra
Administration route: Oral
Start date: 2004-08-31
End date: 2006-09-21
Stavudine
Administration route: Oral
Indication: HIV Infection
Start date: 2002-04-01
End date: 2004-08-04
Tenofovir Disoproxil Fumarate
Administration route: Oral
Indication: HIV Infection
Start date: 2004-08-31
End date: 2006-09-21
Other drugs received by patient: Glycyron; Saquinavir; Allopurinol; Bifidobacterium; Loperamide HCL; Allopurinol
Possible Kaletra side effects in 24 year old male
Reported by a consumer/non-health professional from United States on 2012-08-21
Patient: 24 year old male
Reactions: Pulmonary Hypertension, Palpitations, Dizziness
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Crixivan
Administration route: Oral
Indication: HIV Infection
Start date: 2000-03-18
End date: 2000-05-24
Efavirenz
Dosage: interrupted from 07/25/00 to 09/25/00 24jul-25jul2000,25sep-02oct2000. film coated tab 200 mg
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-10-02
Epivir
Dosage: tabs
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-15
End date: 2008-09-19
Invirase
Dosage: inter:03/18/00-05/24/00,caps 800mg:19jun99-18mar2000.divided dse:24may00-24dec2000,19jun1999-24dc00
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2001-03-31
Kaletra
Dosage: 1df,25dec2000-24apr2004:1217 days
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2004-04-24
Norvir
Dosage: 31mar2001(interrupted).caps 800mg:19jun99-31oct-99.divided dose:01nov99-24dec2000.25apr2004
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2008-09-19
Videx
Dosage: 250,300,400mg12/19/94-3/7/97,3/07/97-7/21/01,7/21/01,125mg,19dc94-7mar97(810d),7mr97-21jl01(1598d)
Administration route: Oral
Indication: HIV Infection
Start date: 1994-12-19
End date: 2001-07-21
Videx EC
Dosage: divided dose
Administration route: Oral
Indication: HIV Infection
Start date: 2001-07-21
End date: 2004-05-14
Zerit
Dosage: 60 mg 8/25/97-27/2/98, 80 mg 2/27-8/3/98, 11/9/98 -6/19/99 and 12/25/00-10/20/01
Administration route: Oral
Indication: HIV Infection
Start date: 1997-08-25
End date: 2001-10-20
Ziagen
Dosage: interrupted from 07/25/00 to 10/20/01 tabs24jul-25jul2000.20oct2001-27oct2001.
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2001-10-27
Other drugs received by patient: Cross Eight M
Possible Kaletra side effects in male
Reported by a physician from France on 2012-08-16
Patient: male
Reactions: Agitation, Urinary Incontinence, Coma, Coma Scale Abnormal, Pyrexia, Hepatotoxicity, Eye Movement Disorder, Hepatosplenomegaly, Anaemia, Malnutrition, General Physical Health Deterioration, Encephalopathy, Faecal Incontinence, Convulsion, Respiratory Tract Congestion, Apathy, Depressed Level of Consciousness, Nervous System Disorder, Confusional State, Immune Reconstitution Syndrome, Snoring, Hepatitis Cholestatic, Intracranial Pressure Increased, Hepatic Ischaemia, Thrombocytopenia, Oxygen Saturation Decreased, Refusal of Treatment by Patient, Necrotising Granulomatous Lymphadenitis, Hepatic Fibrosis, Mycobacterial Infection, Hyponatraemia, Cerebral Atrophy, White Blood Cell Disorder, Renal Failure, Hypoproteinaemia, Diarrhoea, Brain Abscess, Heart Rate Increased, Encephalitic Infection, Heart Sounds Abnormal
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Acetaminophen
Dosage: df 10mg/ml
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Amikacin
Dosage: 900 mg daily
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Bactrim
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Cernevit-12
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Clarithromycin
Dosage: df 50mg/ml
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Folic Acid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Isentress
Administration route: Oral
Indication: HIV Infection
Start date: 2012-05-01
Kaletra
Dosage: df 80/20 mg
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Myambutol
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Nefopam
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Olanzapine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-01
Perikabiven (Parenteral Nutrition)
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Potassium Chloride
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Prazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Rifabutin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Viramune
Indication: HIV Infection
Start date: 2012-03-01
End date: 2012-05-01
Other drugs received by patient: Propofol; Adavat
Possible Kaletra side effects in male
Reported by a physician from France on 2012-08-15
Patient: male
Reactions: Regurgitation, Drooling, Foetal Exposure During Pregnancy, Tracheomalacia, Fungal Infection, Dysphonia, Oral Candidiasis, Foetal Heart Rate Disorder, Oesophageal Atresia, Venous Thrombosis Limb, Cough, Oxygen Saturation Decreased
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Epzicom
Indication: Maternal Exposure Timing Unspecified
Kaletra
Indication: Maternal Exposure Timing Unspecified
Retrovir
Indication: Maternal Exposure Timing Unspecified
Possible Kaletra side effects in male
Reported by a physician from France on 2012-08-15
Patient: male
Reactions: Agitation, Urinary Incontinence, Coma, Pyrexia, Coma Scale Abnormal, Hepatotoxicity, Eye Movement Disorder, Hepatosplenomegaly, Anaemia, Malnutrition, Encephalopathy, Faecal Incontinence, General Physical Health Deterioration, Convulsion, Apathy, Respiratory Tract Congestion, Depressed Level of Consciousness, Nervous System Disorder, Confusional State, Immune Reconstitution Syndrome, Snoring, Hepatitis Cholestatic, Intracranial Pressure Increased, Hepatic Ischaemia, Thrombocytopenia, Oxygen Saturation Decreased, Refusal of Treatment by Patient, Necrotising Granulomatous Lymphadenitis, Hepatic Fibrosis, Mycobacterial Infection, Cerebral Atrophy, Hyponatraemia, Renal Failure, White Blood Cell Disorder, Diarrhoea, Hypoproteinaemia, Heart Rate Increased, Brain Abscess, Encephalitic Infection, Heart Sounds Abnormal
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Acetaminophen
Dosage: df 10mg/ml
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Amikacin
Dosage: 900 mg daily
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Bactrim
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Cernevit-12
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Clarithromycin
Dosage: df 50mg/ml
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Folic Acid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Isentress
Administration route: Oral
Indication: HIV Infection
Start date: 2012-05-01
Kaletra
Dosage: df 80/20 mg
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Myambutol
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Nefopam
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Olanzapine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-01
Perikabiven (Parenteral Nutrition)
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Potassium Chloride
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Prazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Rifabutin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Viramune
Indication: HIV Infection
Start date: 2012-03-01
End date: 2012-05-01
Other drugs received by patient: Adavat; Propofol
Possible Kaletra side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-14
Patient:
Reactions: Coma, Convulsion
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Acetaminophen
Dosage: 500 mg, qd
Start date: 2012-07-11
Acupan
Dosage: 120 mg, qd
Start date: 2012-07-16
End date: 2012-07-27
Amikacin
Dosage: 900 mg, qd
Start date: 2012-07-11
Bactrim
Dosage: 800 mg, qd
Start date: 2012-07-13
Cernevit-12
Dosage: unk
Start date: 2012-07-10
End date: 2012-08-02
Clarithromycin
Dosage: 500 mg, qd
Administration route: Oral
Start date: 2012-07-11
Isentress
Dosage: unk
Administration route: Oral
Indication: HIV Infection
Start date: 2012-05-01
Kaletra
Dosage: unk
Indication: HIV Infection
Start date: 2012-03-01
Leucovorin Calcium
Dosage: unk
Administration route: Oral
Start date: 2012-07-10
Myambutol
Dosage: 1 df, bid
Start date: 2012-07-11
Olanzapine
Dosage: 5 mg, unk
Administration route: Oral
Start date: 2012-01-01
Perikabiven
Dosage: unk
Start date: 2012-07-10
Potassium Chloride
Dosage: unk
Administration route: Oral
Start date: 2012-07-10
Prazepam
Dosage: 1 df, qd
Administration route: Oral
Start date: 2012-07-10
Rifabutin
Dosage: unk
Start date: 2012-07-11
Truvada
Dosage: unk
Indication: HIV Infection
Start date: 2012-03-01
Possible Kaletra side effects in
Reported by a physician from Russian Federation on 2012-08-14
Patient:
Reactions: Atelectasis Neonatal, Neonatal Respiratory Distress Syndrome, Premature Baby, Respiratory Failure, Congenital Hydrocephalus, Foetal Exposure During Pregnancy, Cerebral Atrophy, Cerebellar Hypoplasia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Kaletra
Possible Kaletra side effects in 41 year old female
Reported by a physician from Thailand on 2012-08-13
Patient: 41 year old female
Reactions: Anaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Lamivudine; Zidovudine
Possible Kaletra side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-13
Patient: male
Reactions: Confusional State, Agitation, Refusal of Treatment by Patient, Malnutrition, Anaemia, Coma, General Physical Health Deterioration, Pyrexia, Convulsion, Apathy, Hepatotoxicity, Diarrhoea, Thrombocytopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Acetaminophen
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Acupan
Dosage: 120 mg, unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-16
End date: 2012-07-27
Amikacin
Dosage: 900 mg, unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Bactrim
Dosage: 800 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-13
Cernevit / 01027001 /
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-08-02
Clarithromycin
Dosage: 500 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Isentress
Dosage: unk
Administration route: Oral
Indication: HIV Infection
Start date: 2012-05-01
Kaletra
Dosage: unk
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Leucovorin Calcium
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Myambutol
Dosage: 2 df, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Olanzapine
Dosage: 1 df, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-01
Perikabiven
Dosage: unk
Indication: Parenteral Nutrition
Start date: 2012-07-10
Potassium Chloride
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Prazepam
Dosage: 1 df, qd
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Rifabutin
Dosage: 150 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Truvada
Dosage: unk
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Possible Kaletra side effects in male
Reported by a physician from France on 2012-08-02
Patient: male, weighing 4.7 kg (10.3 pounds)
Reactions: Hypothermia, Foetal Exposure During Pregnancy, Anaemia, Tachycardia, Lactic Acidosis, Foetal Distress Syndrome, Apparent Death, Electroencephalogram Abnormal, Renal Failure, Rash Erythematous, Thrombocytopenia, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Indication: Prophylaxis
Start date: 2011-01-01
End date: 2012-06-26
Kaletra
Indication: Prophylaxis
Start date: 2011-01-01
End date: 2012-06-26
Retrovir
Start date: 2012-06-26
End date: 2012-06-29
Retrovir
Indication: Prophylaxis
Start date: 2012-06-26
End date: 2012-06-26
Possible Kaletra side effects in male
Reported by a physician from Chile on 2012-07-31
Patient: male, weighing 87.0 kg (191.4 pounds)
Reactions: Asthmatic Crisis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Lamivudine (Epivir Hbv)
Possible Kaletra side effects in male
Reported by a physician from France on 2012-07-27
Patient: male
Reactions: Foetal Exposure During Pregnancy, Anaemia, Lactic Acidosis, Ill-Defined Disorder, Hepatic Enzyme Increased, Apparent Death, Foetal Distress Syndrome, Renal Failure, C-Reactive Protein Increased, Thrombocytopenia, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Indication: Maternal Exposure Timing Unspecified
Kaletra
Indication: Maternal Exposure Timing Unspecified
Retrovir
Indication: Prophylaxis Against HIV Infection
Start date: 2012-06-26
End date: 2012-06-26
Retrovir
Indication: Maternal Exposure Timing Unspecified
Possible Kaletra side effects in male
Reported by a physician from Germany on 2012-07-26
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Leishmaniasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Truvada
Possible Kaletra side effects in male
Reported by a physician from France on 2012-07-20
Patient: male
Reactions: Foetal Exposure During Pregnancy, Anaemia, Lactic Acidosis, Ill-Defined Disorder, Hepatic Enzyme Increased, Apparent Death, Foetal Distress Syndrome, Renal Failure, C-Reactive Protein Increased, Thrombocytopenia, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Indication: Maternal Exposure Timing Unspecified
Kaletra
Indication: Maternal Exposure Timing Unspecified
Retrovir
Indication: Prophylaxis Against HIV Infection
Start date: 2012-06-26
End date: 2012-06-26
Retrovir
Indication: Maternal Exposure Timing Unspecified
Possible Kaletra side effects in male
Reported by a physician from France on 2012-07-17
Patient: male, weighing 4.7 kg (10.3 pounds)
Reactions: Hypothermia, Tachycardia, Foetal Exposure During Pregnancy, Anaemia, Lactic Acidosis, Electroencephalogram Abnormal, Foetal Distress Syndrome, Apparent Death, Renal Failure, Rash Erythematous, Thrombocytopenia, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Indication: Prophylaxis
Start date: 2011-01-01
End date: 2012-06-26
Kaletra
Indication: Prophylaxis
Start date: 2011-01-01
End date: 2012-06-26
Retrovir
Start date: 2012-06-26
End date: 2012-06-29
Retrovir
Indication: Prophylaxis
Start date: 2012-06-26
End date: 2012-06-26
Possible Kaletra side effects in male
Reported by a physician from France on 2012-07-16
Patient: male
Reactions: Anaemia, Foetal Exposure During Pregnancy, Lactic Acidosis, Ill-Defined Disorder, Hepatic Enzyme Increased, Foetal Distress Syndrome, Apparent Death, Renal Failure, C-Reactive Protein Increased, Thrombocytopenia, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Indication: Maternal Exposure Timing Unspecified
Kaletra
Indication: Maternal Exposure Timing Unspecified
Retrovir
Indication: Maternal Exposure Timing Unspecified
Retrovir
Indication: Prophylaxis Against HIV Infection
Start date: 2012-06-26
End date: 2012-06-26
Possible Kaletra side effects in male
Reported by a physician from Russian Federation on 2012-07-03
Patient: male
Reactions: Blood Cholesterol Increased, Myocardial Infarction
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Dosage: 1tab per day
Administration route: Oral
Indication: HIV Infection
Start date: 2011-04-20
Combivir
Indication: HIV Infection
Start date: 2007-01-01
Isentress
Administration route: Oral
Indication: HIV Infection
Start date: 2011-04-20
Kaletra
Indication: HIV Infection
Start date: 2007-01-01
Possible Kaletra side effects in
Reported by a physician from Russian Federation on 2012-06-27
Patient:
Reactions: Foetal Exposure During Pregnancy, Cerebral Atrophy, Hydrocephalus
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Kaletra
Possible Kaletra side effects in female
Reported by a pharmacist from United States on 2012-06-25
Patient: female, weighing 1.0 kg (2.2 pounds)
Reactions: Premature Baby, Atrioventricular Block Complete, Maternal Exposure During Pregnancy, Toxicity To Various Agents, Cardiomyopathy
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Kaletra
Dosage: 460/115 mg/m**2 per day
Indication: Prophylaxis Against HIV Infection
Start date: 2006-12-10
Lamivudine
Indication: Prophylaxis Against HIV Infection
Start date: 2006-12-10
Lamivudine
Indication: Maternal Exposure Timing Unspecified
Lopinavir and Ritonavir
Indication: Maternal Exposure Timing Unspecified
Tenofovir Disoproxil Fumarate
Indication: Maternal Exposure Timing Unspecified
Tenofovir Disoproxil Fumarate
Start date: 2006-12-10
Zidovudine
Indication: Prophylaxis Against HIV Infection
Start date: 2006-12-10
Possible Kaletra side effects in male
Reported by a pharmacist from United States on 2012-06-25
Patient: male, weighing 1.1 kg (2.4 pounds)
Reactions: Premature Baby, Maternal Exposure During Pregnancy, Atrioventricular Block Complete, Toxicity To Various Agents, Cardiomyopathy
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Kaletra
Dosage: 460/115 mg/m**2 per day
Indication: Prophylaxis Against HIV Infection
Start date: 2006-12-10
Lamivudine
Indication: Maternal Exposure Timing Unspecified
Lamivudine
Indication: Prophylaxis Against HIV Infection
Start date: 2006-12-10
Lopinavir and Ritonavir
Indication: Maternal Exposure Timing Unspecified
Tenofovir Disoproxil Fumarate
Indication: Maternal Exposure Timing Unspecified
Zidovudine
Indication: Prophylaxis Against HIV Infection
Start date: 2006-12-10
Possible Kaletra side effects in female
Reported by a physician from Botswana on 2012-06-01
Patient: female
Reactions: Anaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Lamivudine + Zidovudine
Possible Kaletra side effects in 67 year old male
Reported by a physician from Greece on 2012-05-30
Patient: 67 year old male
Reactions: Superinfection, Acute Hepatic Failure, Hepatitis D, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Kaletra
Indication: Hepatitis B
Kaletra
Indication: HIV Infection
Other drugs received by patient: Tenofovir + Emtricitabine (Truvanta); Steroids; Methotrexate; Tenofovir + Emtricitabine (Truvanta); Remicade; Emtricitabine
Possible Kaletra side effects in 52 year old male
Reported by a physician from United Kingdom on 2012-05-07
Patient: 52 year old male, weighing 68.0 kg (149.6 pounds)
Reactions: Weight Decreased, Renal Cancer Metastatic, Lymphadenopathy, Lung Neoplasm, Renal Mass, Metastases To Bone, Metastases To Lung
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Abacavir Sulfate / Lamivudine; Opioids; Analgesia
Possible Kaletra side effects in 67 year old male
Reported by a physician from Greece on 2012-05-07
Patient: 67 year old male
Reactions: Superinfection, Acute Hepatic Failure, Hepatitis D, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Kaletra
Indication: HIV Infection
Kaletra
Indication: Hepatitis B
Other drugs received by patient: Remicade; Emtricitabine; Methotrexate; Steroids; Tenofovir + Emtricitabine (Truvanta); Tenofovir + Emtricitabine (Truvanta)
Possible Kaletra side effects in 52 year old male
Reported by a physician from United Kingdom on 2012-05-02
Patient: 52 year old male, weighing 68.0 kg (149.6 pounds)
Reactions: Weight Decreased, Renal Cancer Metastatic, Lymphadenopathy, Lung Neoplasm, Metastases To Bone, Renal Mass, Metastases To Lung
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Analgesia; Abacavir Sulfate / Lamivudine; Opioids
Possible Kaletra side effects in 42 year old male
Reported by a physician from Germany on 2012-04-30
Patient: 42 year old male, weighing 54.0 kg (118.8 pounds)
Reactions: Ruptured Cerebral Aneurysm, Subarachnoid Haemorrhage, Hemiparesis, Cerebrovascular Spasm
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Raltegravir
Possible Kaletra side effects in 67 year old male
Reported by a physician from Greece on 2012-04-12
Patient: 67 year old male
Reactions: Superinfection, Acute Hepatic Failure, Hepatitis D, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Kaletra
Indication: HIV Infection
Kaletra
Indication: Hepatitis B
Other drugs received by patient: Tenofovir + Emtricitabine (Truvanta); Tenofovir + Emtricitabine (Truvanta); Remicade; Steroids; Methotrexate
Page 1 Next >>
|
